METHODOLOGY PAPER
Best practices for the expansion of smoke-free and aerosol-free environments in Europe: Protocol for the consultation to experts
More details
Hide details
1
Tobacco Control Unit, Catalan
Institute of Oncology - WHO
Collaborating Centre for Tobacco
Control, l’Hospitalet de Llobregat,
Catalonia, Spain
2
Tobacco Control Research
Group, Bellvitge Biomedical
Research Institute, l’Hospitalet de
Llobregat, Catalonia, Spain
3
Centre for Biomedical Research
in Respiratory Diseases, Institute
of Health Carlos III, Madrid, Spain
4
Institute of Public Health of
Serbia "Dr Milan Jovanovic Baut",
Belgrade, Serbia
5
Health Services Management
Training Centre, Semmelweis,
Hungary
6
National Korányi Institute of
Pulmonology, Budapest, Hungary
7
Department of Medical
Epidemiology, Istituto Di Ricerche
Farmacologiche Mario Negri
IRCCS, Milan, Italy
8
Group of Evaluation of Health
Determinants and Health
Policies, Faculty of Medicine
and Health Sciences, Basic
Sciences Department, Universitat
Internacional de Catalunya,
Catalonia, Spain
9
National Institute of Public
Health, Ljubljana, Slovenia
10
Institute for Cancer Research,
Prevention and Clinical Network
(ISPRO), Florence, Italy
11
Department of Clinical
Sciences, Faculty of Medicine and
Health Sciences, University of
Barcelona, Barcelona, Spain
Submission date: 2024-03-15
Final revision date: 2024-08-13
Acceptance date: 2024-08-30
Publication date: 2024-10-18
Corresponding author
Dolors Carnicer-Pont
Institut Català d'Oncologia - Institut d'Investigació Biomèdica de Bellvitge - Universitat de Barcelona ICO-IDIBELL-UB
Tob. Prev. Cessation 2024;10(October):44
KEYWORDS
TOPICS
ABSTRACT
Smoke-free legislation has been shown to positively impact reducing secondhand
smoke (SHS) exposure, especially in countries that have implemented comprehensive
legislation rather than partial bans. Also, secondhand aerosols (SHA) that come from
the heating of tobacco or liquids, with or without nicotine, in electronic nicotine
delivery systems (ENDS) have been proven to increase levels of harmful substances
in the air. Therefore, protection against SHS and SHA exposure and expansion
of smoke- and aerosol-free environments (SAFE) should be taken into account
when creating or trying to expand or enforce clean air policies. This article aims to
present the protocol for a consultation with experts on tobacco and nicotine control
in order to identify best practices, barriers, and opportunities for the expansion
of SAFE in Europe. We identified experts among policymakers, researchers, and
tobacco regulators in European countries and invited them to participate in the
consultation by completing an online survey designed, programmed, and pilot-tested
using Survey Monkey. The responses to the questionnaire contained quantitative
and qualitative information that was thematically analyzed. The experts’ consultation
allowed us to produce a report on barriers and opportunities for SAFE, a report and
a position paper on SAFE best practices, a web-based repository of best practices,
and a weight of evidence paper that assembles evidence supporting the expansion
of SAFE on indoor and outdoor spaces.
INTRODUCTION
Smoke-free legislation has been shown to be effective and have a positive impact on the population’s health1, as people who live in countries that have smoke-free bans are less exposed to secondhand smoke (SHS), especially if they have comprehensive legislation rather than partial bans2. Moreover, smoke-free legislation could also change behaviors beyond the ban itself, such as not smoking at home3,4 and reducing smoking prevalence, mostly among women5. However, not only traditional tobacco products and SHS should be considered when talking about smoke-free environments6. The use of electronic cigarettes (e-cigarettes) or heated tobacco products (HTPs) produces aerosols containing different hazardous substances7,8 that are exhaled by users as secondhand aerosols (SHA).
There is growing evidence supporting the health harm of SHA, which contains numerous toxic and carcinogenic substances9,10, Moreover, the use of e-cigarettes and HTPs increases levels of harmful substances in the air of enclosed places-11,12,13,14. However, most of the legislations in the WHO European Region are not comprehensive enough when it comes to e-cigarettes and HTPs10. Therefore, protection against SHA should be taken into account when creating or trying to expand or enforce clean air policies8.
Another challenge is the lack of legislative solutions regarding smoke- and aerosol-free environments (SAFE). Regardless of some common regional regulation, such as the Tobacco Products Directive (TPD)15 in the European Union (EU) or, more globally, the WHO Framework Convention for Tobacco Control (FCTC)16, the level of protection offered to non-smokers varies depending on the country they live, and this is mainly a consequence of differences between clean air policies across countries2. Additionally, we must take into account that there are also differences in the terms of compliance and enforcement of these legislations17.
As acknowledged in recent global reports on the tobacco epidemic and tobacco control18,19, nations are progressively expanding smoke-free regulations to encompass outdoor spaces. Despite the decline in SHS exposure attributable to the positive impact of effective legislation, substantial exposure still persists in certain public and private settings, such as bars and restaurants, or homes and cars20.
To support further progress in protection from SHA and SHS, Work Package 8 of the Second Joint Action for Tobacco Control (JATC2) aimed to outline and disseminate best practices in order to address the upcoming challenges for smoke-free environments in Europe. For this purpose, a consultation with European experts on best practices, barriers, and opportunities to expand SAFE was designed.
This article aims to present the protocol used to identify best practices, barriers, and opportunities to protect people from exposure to SHS and SHA produced by e-cigarettes, HTPs, and other tobacco or nicotine products.
METHODOLOGICAL APPROACH
Identification and selection of experts
We applied several methods to identify and involve tobacco control experts across Europe in our consultation. First, the JATC2 employed a contact list of all partners and their affiliated authorities, institutes, or organizations working in the field of tobacco control (policymakers, regulators, researchers, tobacco inspectors, NGO activists) partners from EU Member States, as well as non-EU countries of Europe. Second, the Catalan Institute of Oncology, a WHO Collaborating Centre for Tobacco Control, provided its list of contacts, including speakers and attendees, to five editions of five ICO-WHO Symposia on tobacco control. Third, the Smoke-Free Partnership (SFP) and the European Network for Smoking and Tobacco Prevention (ENSP) were requested to provide their list of contacts, partners, and members for the JATC2 consultation. From all of these sources, we identified 110 experts from 30 European countries (27 EU Member States, Norway, Serbia, and the United Kingdom).
Inviting experts to participate in the consultation
All of the identified experts were invited by e-mail to participate in the consultation. The invitation email explained the objectives of the consultation, the instructions to complete the online questionnaire, and the links to access both Section 1 and Section 2. After accepting the invitation for the consultation, the experts were sent the online questionnaire gathering information on any type of SAFE, including both public and private environments and outdoor and enclosed places. After acceptance, the experts were sent an online questionnaire gathering information on any type of smoke-free environment, including both private and public environments, outdoor and enclosed places, and protection from tobacco smoke or exposure to aerosols from HTPs or e-cigarettes. Of the 110 invited experts, 61 (response rate of 55.4%) from 29 EU countries (Austria, Belgium, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxemburg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Slovenia, Spain, Sweden and United Kingdom of Great Britain and Northern Ireland) provided full or partial answers to the online questionnaire (Supplementary file)
Designing, programming, and testing the online questionnaire
The online questionnaire21 contained a compulsory information and consent form, as well as two other sections. Section 1, with 26 questions (nine on sociodemographic information, 9 open-ended, and 8 open questions), explored the comprehensiveness of existing smoke- and aerosol-free legislation, perceived compliance, perceived barriers, and opportunities for expansion. The first section also explored the extent of tobacco industry interference. Section 2 included 42 questions: 16 open-ended and 26 open questions, allowing national experts to provide detailed information through text or links about practices that are considered best practices on SAFE. The online questionnaire was programmed using Survey Monkey. It included multiple choice quantitative closed-questions and qualitative open-ended questions and also allowed the attachment of documents or links to some questions. Testing of the questionnaire was conducted by the WP8 partners, who, after filling it in, provided feedback about the duration, readability, and comprehensibility of the questionnaire.
Completing the survey filling in and data collection
Each respondent was asked to report information on up to four best practices and to provide four specific online links for each best practice. Since the questionnaire had more than 60 questions and many of them required detailed descriptions, the process of filling it in required a median of two days (two entries) for most of the respondents. The questionnaire was structured to enable experts to pause, save, and resume completion at the precise point where it was initially suspended.
The follow-up of data collection was conducted weekly by programmed routines in Survey Monkey, including follow-up of the status of completion of questionnaires for each expert and reminders to continue with the task. The questionnaire was accessible for a duration of up to 12 weeks from its launch date on the 15 June up to the 15 August 2022.
Data handling and record keeping
All data were stored in Excel and transferred to Stata for analysis. A web-based repository with all best practices on SAFE reported was created and is currently fully functional.
Data analysis
Step 1
We assessed response rate, namely the number of answers received (total and per country; % of non-response); the number of Best Practices (BP) received per country; completeness of received questionnaires (overall %; and question-specific details) and the correctness of links and/or documents provided.
Step 2
Descriptive analyses were conducted to explore the distribution of BP topics. The quantitative variables of the practices, barriers, and opportunities and each category are presented in Tables 1 and 2.
Table 1
Quantitative variables to assess best practices on SAFE
Variables | Categories |
---|
Type of practice | Information/awareness raising program Policy Action plan Regulation/ban Monitoring/surveillance Service delivery approach/method Tool/instrument Guideline Training E-health – mHealth Health in all policies Don’t know |
Phase of the practice | Practice is at the first stage of implementation but not yet totally developed Practice has been developed/adopted but not yet enforced Practice has been implemented (enforced/promoted) Practice has been evaluated Practice has been registered in a best practice registering portal Don’t know |
Responsibility for the practice | Municipality/city Province/region Nation Public agency University Government NGOs Private institution Don’t know |
Duration of the practice | Practice is ongoing Practice has ended Don’t know |
Start and end date of the practice | |
Scope of the practice | International National Regional Local |
Funding of the practice | Own resources External resources – public External resources – private excluding the tobacco or nicotine industry External resources – private including the tobacco or nicotine industry No funds required Don’t know |
Objectives of the practice | Smoke-free indoor settings (conventional tobacco products) Smoke-free outdoor settings (conventional tobacco products) Voluntary home smoking ban (conventional tobacco products) Car smoking ban with minors or pregnant women (conventional tobacco products) Car smoking ban also without minors or pregnant women (conventional tobacco products) Smoking ban as an anti-COVID-19 measure Indoor aerosol-free regulation for e-cigarettes Outdoor aerosol-free regulation for e-cigarettes Voluntary home aerosol ban regulation for e-cigarettes Car vaping ban with minors or pregnant women Car vaping ban also without minors or pregnant women Vaping ban as an anti-COVID-19 measure Indoor aerosol-free regulation for heated tobacco products Outdoor aerosol-free regulation for heated tobacco products Voluntary vaping ban regulation for heated tobacco products Car heated tobacco product ban with minors or pregnant women Car heated tobacco product ban also without minors or pregnant women Ban of heated tobacco products use as an anti-COVID-19 measure |
Target settings | Restaurants and bars (indoor) Hotels (indoor) Train stations and public transports (indoor) Airports (indoor) Workplace (indoor) Schools/public education institutions/educational venues except universities (indoor) Universities (indoor) Cinemas/theatres (indoor) Hospitals including outpatient clinics (indoor) Primary health care institutions (indoor) Institutions from social sector (indoor) Prisons (indoor) Cars Home Restaurants’ patios/terraces (outdoor) Bus, tramway, trolley-bus stop waiting areas (outdoor) Parks (outdoor) Underpass (outdoor) Stadiums and outdoor arenas (outdoor) Beaches (outdoor) Outdoor areas of hospitals and healthcare institutions (outdoor); Outdoor areas of school (outdoor) Children’s playgrounds (outdoor) |
Target population | General population Gender specific groups Age specific groups Socioeconomic position (including educational level) Certain levels in education system Cultural/ethnic background Vulnerable groups (Disability) Vulnerable groups (Diseases) Vulnerable groups (Prisoners) Vulnerable groups (Sexual diversity; e.g. LGBTQ) Vulnerable groups (Pregnant women) Vulnerable groups (Immigrants/refugees) Urban setting Rural settings Don’t know |
Involvement of the target population in development; implementation or evaluation of the practice | International/European public health authorities National public health authorities Regional public health authorities Local public health authorities Hospital staff Primary care center staff Specialized physicians General practitioners Pharmacists Nurses Other health care professionals Informal caregivers Researchers/academics School/kindergarten teachers Employers/employees Civil society |
Enforcement of the practice | Yes No |
Evaluation of the practice | Yes, by an external partner Yes, the evaluation was carried out internally Not yet, the intervention is still ongoing but the evaluation is foreseen No Don’t know |
Transferability of the practice | Transferability has not been considered Practice has been implemented on local/regional/national level and transferability has not been considered in a systematic way Ready for transfer, but the practice has not been transferred yet Practice has been developed on local/regional/national level and transferability has been considered and structural, political and systematic recommendations have been presented. However, the practice has not been transferred yet Practice has been transferred (i.e. scaled-up) within the same country/region Practice has been scaled-up to other locations or regions or at national scale in the same country |
Sustainability | Practice has institutional support and stable human resources Practice provides training of staff in order to sustain it A sustainability strategy has been developed None of the above options |
Table 2
Quantitative variables to assess barriers and opportunities for expansion of compliance with and enforcement of SAFE
Variables | Response categories |
---|
In your country, can you identify any barriers for the expansion of smoke and aerosol-free environment policies? | Yes/no |
In your country, can you identify any barriers to the improvement of compliance with (or enforcement of) smoke and aerosol-free environment policies? | Yes/no |
In your country, to what extent do you think the tobacco or nicotine industries (and their allies) are interfering with the expansion of smoke and aerosol-free environments? | No interference Small Moderate Large Very large interference |
In your country, to what extent do you think the tobacco or nicotine industries (and their allies) are interfering with the enforcement of smoke and aerosol-free environments? | No interference Small Moderate Large Very large interference |
In your country, can you identify any opportunities for the expansion of smoke and aerosol-free environment policies? | Yes/no |
In your country, can you identify any opportunities for the improvement of compliance with (or enforcement of) smoke and aerosol-free environment policies? | Yes/no |
Ethical considerations
Informed consent was obtained by ticking affirmatively the two final questions of the first page of the online questionnaire: 1) ‘I understand and agree that the provided information is correct and may be used by the WP8 leaders for the purposes indicated’; and 2) ‘I understand and agree that my name and institution can be listed in the JATC-2 website and reports. Experts had the right to withdraw at any point of the consultation.
Conflicts of interest
All the experts were asked about potential conflicts of interest with the aim of the consultation. No experts with links to the tobacco and/or electronic cigarette industry were included in the experts’ panel.
DISCUSSION
Quantitative variables addressing best practices and allowing multiple choice responses were analyzed as a number of responses (frequencies) for each category of the variable. A number of practices and percentages were calculated for the single-choice response variables. Qualitative open-ended questions addressed best practices, and careful reading of each practice allowed the classification of the practice into groups. A series of thematic analyses were conducted using subjective coding systems by three members of Work Package 8 of the Joint Action on Tobacco Control 2. Responses were categorized thematically using the Title of the practice as a reference to group the practices into a broader group ‘type of setting’. Finally, the list and details of each practice were placed in a Web-based repository.
Qualitative open-ended questions addressing barriers and opportunities, a series of thematic analyses were conducted using subjective coding systems by three members of Work Package 8 of the Joint Action on Tobacco Control 2. Responses were first categorized thematically; however, this classification resulted in a high number of categories (n=11–15) that were difficult to overview. Therefore, as a second step, we collapsed these into broader thematic categories (n=5–6). Finally, these categories were presented in tables as numbers and percentages of the total responses, taking the total number of experts as the denominator.
Additional information on best practices was obtained by web links and PDF documents uploaded while answering the survey. We conducted best practices content analysis and summarized it in a narrative report to allow synthesis and readability of the results.
CONCLUSIONS
This protocol has been a guide for all the foreseen activities related to the identification of best practices to expand SAFE in European countries. It allowed us to systematically work on the online consultation with experts22, the report of the symposium with experts, the reports on best practices23, barriers, and opportunities for SAFE24, the web-based repository25, the weight of evidence26, and finally, the position paper for SAFE27.
ACKNOWLEDGEMENTS
The authors acknowledge the valuable contributions of the following
experts who participated in the consultation on Smoke- and Aerosol-
Free Environments in the EU: Aive Telling, Alexandra Pankova, Andreas
Weinseiss, Astrid Knudsen, Barbara Kocjan Slapar, Biljana Kilibarda,
Catherine Charpentier, Christa Rustler, Christine Baluci, Constantine
Vardavas, Daniëlle Arnold, Dražen Pavasović, Emmanuelle Beguinot, Esther
Croes, Eva Kralikova, Helena Koprivnikar, Helena Wilson, Herodotos
Herodotou, Ioanna Parara, Iveta Pudule, Judit Kiss, Kamran Siddiqi,
Katalin Bitó, Katrin Schaller, Kristin Byrkje, Kristina Aidla, Linda Karlsson,
Lisbeth Holm Olesen, Lorenzo Spizzichino, Lucienne Thommes, Magdalena
Ciobanu, Manfred Neuberger, Mara van Dooremal, Maria Karekla, Maria
Alejandra Cardenas, Maria Sofia Cattaruzza, Marie Nejedla, Martina Blake,
Mateusz Jankowski, Mathieu Capouet, Maurice Mulcahy, Meri Paavola,
Mirjana Kujundžić Tiljak, Nataša Blažko, Neža Polh, Nicole Schager, Nijole
Gostautaite Midttun, Patrick Goodman, Pedro Marques, Pieter Rijswijk,
Raquel Fernández-Megia, Reet Pruul, Reina de Kinder, Sanita Lazdina,
Sean Sempre, Sebastiaan de Groot, Sofia Ravara, Soula Ioannou, Suzanne
Gabriels, Suzanne Dowd, Sylvia Sklárová, Tibor Demjén, Timea Záluszká, Ulf
Bergsten, Una Martinsone, Veerle Maes, Viktor Mravcik, Waltraud Posch.
CONFLICTS OF INTEREST
The authors have completed and submitted the ICMJE Form for Disclosure
of Potential Conflicts of Interest and none was reported.
FUNDING
This research was co-funded by the European Union’s Health Program
under Grant Agreement No. 101035968/ JA-01-2020 (HaDEA). DCP, AML
and EF are partially supported by the Department of Universities and
Research, Government of Catalonia (2021 SGR 00906) and acknowledge
CERCA institutional support to IDIBELL.
ETHICAL APPROVAL AND INFORMED CONSENT
Ethical approval and informed consent were not required for this study.
DATA AVAILABILITY
The data supporting this research are available from the authors on
reasonable request.
AUTHORS' CONTRIBUTIONS
Conceptualization: DCP, AML and EF. Methodology: DCP, AML, BK, MV,
MP, CS and EF. Formal analysis: BK, MV, MP, CS, and EF. Validation and
data curation: BK, MV, MP and CS. Project administration: AML. Funding
acquisition: EF. Supervision: DCP and EF. Writing of original draft: DCP,
AML, and EF. Writing, reviewing and editing: all authors. Read and approved
the final version of the manuscript: all authors.
PROVENANCE AND PEER REVIEW
Not commissioned; externally peer-reviewed.
REFERENCES (27)
1.
Gao M, Li Y, Wang F, et al. The effect of smoke-free legislation on the mortality rate of acute myocardial infarction: a meta-analysis. BMC Public Health. 2019;19(1):1269. doi:10.1186/s12889-019-7408-7
2.
Schiavone S, Anderson C, Mons U, Winkler V. Prevalence of second-hand tobacco smoke in relation to smoke-free legislation in the European Union. Prev Med. 2022;154:106868. doi:10.1016/j.ypmed.2021.106868
3.
Mons U, Nagelhout GE, Allwright S, et al. Impact of national smoke-free legislation on home smoking bans: findings from the International Tobacco Control Policy Evaluation Project Europe Surveys. Tob Control. 2013;22(e1):e2-e9. doi:10.1136/tobaccocontrol-2011-050131
4.
Tattan-Birch H, Jarvis MJ. Children's exposure to second-hand smoke 10 years on from smoke-free legislation in England: Cotinine data from the Health Survey for England 1998-2018. Lancet Reg Health Eur. 2022;15:100315. doi:10.1016/j.lanepe.2022.100315
5.
Bird Y, Kashaniamin L, Nwankwo C, Moraros J. Impact and Effectiveness of Legislative Smoking Bans and Anti-Tobacco Media Campaigns in Reducing Smoking among Women in the US: A Systematic Review and Meta-Analysis. Healthcare (Basel). 2020;8(1):20. doi:10.3390/healthcare8010020
6.
Gallus S, Fernandez E. Reaping what you sow: England's drastic reduction in childhood secondhand smoke exposure in two decades. Lancet Reg Health Eur. 2022;15:100334. doi:10.1016/j.lanepe.2022.100334
7.
Amalia B, Liu X, Lugo A, et al. Exposure to secondhand aerosol of electronic cigarettes in indoor settings in 12 European countries: data from the TackSHS survey. Tob Control. 2021;30(1):49-56. doi:10.1136/tobaccocontrol-2019-055376
8.
Fernández E, Ballbè M, Sureda X, Fu M, Saltó E, Martínez-Sánchez JM. Particulate Matter from Electronic Cigarettes and Conventional Cigarettes: a Systematic Review and Observational Study. Curr Environ Health Rep. 2015;2(4):423-429. doi:10.1007/s40572-015-0072-x
9.
Haggart K, Robertson L, Blank ML, Popova L, Hoek J. It's Just Steam: a qualitative analysis of New Zealand ENDS users' perceptions of secondhand aerosol. Tob Control. 2021;30(1):30-35. doi:10.1136/tobaccocontrol-2019-055368
10.
Amalia B, Fu M, Feliu A, et al. Regulation of Electronic Cigarette Use in Public and Private Areas in 48 Countries Within the WHO European Region: A Survey to In-country Informants. J Epidemiol. 2022;32(3):131-138. doi:10.2188/jea.JE20200332
11.
Li L, Lin Y, Xia T, Zhu Y. Effects of Electronic Cigarettes on Indoor Air Quality and Health. Annu Rev Public Health. 2020;41:363-380. doi:10.1146/annurev-publhealth-040119-094043
12.
Schober W, Fembacher L, Frenzen A, Fromme H. Passive exposure to pollutants from conventional cigarettes and new electronic smoking devices (IQOS, e-cigarette) in passenger cars. Int J Hyg Environ Health. 2019;222(3):486-493. doi:10.1016/j.ijheh.2019.01.003
13.
Cancelada L, Sleiman M, Tang X, et al. Heated Tobacco Products: Volatile Emissions and Their Predicted Impact on Indoor Air Quality. Environ Sci Technol. 2019;53(13):7866-7876. doi:10.1021/acs.est.9b02544
14.
WHO. WHO study group on tobacco product regulation:Report on the scientific basis of tobacco product regulation: eighth report of a WHO study group. WHO; 2021. May 4, 2021. Accessed August 13, 2024.
https://www.who.int/publicatio...
15.
Tobacco Products Directive. Directive 2014/40/eu of the european parliament and of the council of 3 April 2014 on the approximation of the laws, regulations and administrative provisions of the Member States concerning the manufacture, presentation and sale of tobacco and related products and repealing Directive 2001/37/EC. Accessed August 13, 2024.
https://health.ec.europa.eu/sy...
16.
Shibuya K, Ciecierski C, Guindon E, et al. WHO Framework Convention on Tobacco Control: development of an evidence based global public health treaty. BMJ. 2003;327(7407):154-157. doi:10.1136/bmj.327.7407.154
17.
Semple S, Dobson R, O'Donnell R, et al. Smokefree spaces: a decade of progress, a need for more?. Tob Control. 2022;31(2):250-256. doi:10.1136/tobaccocontrol-2021-056556
20.
Fu M, Castellano Y, Tigova O, et al. Prevalence and correlates of different smoking bans in homes and cars among smokers in six countries of the EUREST-PLUS ITC Europe Surveys. Tob Induc Dis. 2019;16:A8. doi:10.18332/tid/94827
21.
Questionnaire to identify relevant policies and best practices about smoke and aerosol- free environments in Europe. Accessed August 13, 2024.
https://www.icoprevencio.cat/u...
22.
JATC2-WP8 Symposium: Learning from practices toimprove Smoke and AerosolFree Environments (SAFE) in Europe. JATC. Accessed August 13, 2024.
https://www.icoprevencio.cat/u...
26.
Weight of evidence paper on barriers, opportunities and best practices for Smoke and Aerosol Free Environments (SAFE) expansion and SHS/SHA exposure protection. JATC. Accessed August 13, 2024.
https://www.icoprevencio.cat/u...
CITATIONS (1):
1.
Barriers and opportunities for the expansion of smoke- and aerosol-free environment policies in Europe
Melinda Pénzes, Dolors Carnicer-Pont, Anna Mar López Luque, Helena Koprivnikar, Biljana Kilibarda, Milena Vasic, Adrián González-Marrón, Irene Possenti, Silvano Gallus, Angeliki Lambrou, Efstathios Papachristou, Sotiria Schoretsaniti, Giulia Carreras, Giuseppe Gorini, Esteve Fernández
Tobacco Prevention & Cessation